HIGHLIGHTS
- who: Xuhui Ma from the (UNIVERSITY) have published the Article: EGFR blockade confers sensitivity to cabozantinib in hepatocellular carcinoma, in the Journal: (JOURNAL)
- how: The results indicated that cabozantinib or WZ3146 alone slightly suppressed growth of patient-derived organoids while their combination significantly inhibited cell viability in both HCC organoids suggesting a strong synergy between cabozantinib and WZ3146 (Fig 1p).
SUMMARY
Cell Discovery CORRESPONDENCE Open Access EGFR blockade confers sensitivity to cabozantinib in hepatocellular carcinoma Xuhui Ma1, Shanshan Wu1, Botai Li1,2, Qianqian Zhang3, Jianming Zhang René Bernards 1,6 ✉, Wenxin . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.